HCA Healthcare, Inc. $HCA is Longview Partners Guernsey LTD's 7th Largest Position

Key Points

• Longview Partners Guernsey LTD has reduced its stake in HCA Healthcare by 5.8%, owning about 1,658,478 shares, which is approximately 0.69% of the company's overall value.
• HCA Healthcare reported earnings of $6.84 per share for the last quarter, surpassing analyst expectations and indicating a year-over-year revenue growth of 6.4% with total revenue of $18.61 billion.
• The company declared a quarterly dividend of $0.72, representing an annualized yield of 0.7%, with shareholders of record set to receive the payment on September 30th.

Longview Partners Guernsey LTD cut its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 5.8% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,658,478 shares of the company's stock after selling 102,060 shares during the period. HCA Healthcare accounts for 4.6% of Longview Partners Guernsey LTD's portfolio, making the stock its 7th biggest position. Longview Partners Guernsey LTD owned approximately 0.69% of HCA Healthcare worth $573,087,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in HCA. Cheviot Value Management LLC purchased a new stake in HCA Healthcare in the first quarter worth $26,000. Atwood & Palmer Inc. purchased a new stake in HCA Healthcare in the first quarter worth $28,000. Bartlett & CO. Wealth Management LLC grew its stake in HCA Healthcare by 888.9% in the first quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock worth $31,000 after purchasing an additional 80 shares during the period. ORG Partners LLC grew its stake in HCA Healthcare by 344.0% in the first quarter. ORG Partners LLC now owns 111 shares of the company's stock worth $38,000 after purchasing an additional 86 shares during the period. Finally, Migdal Insurance & Financial Holdings Ltd. grew its stake in HCA Healthcare by 75.8% in the first quarter. Migdal Insurance & Financial Holdings Ltd. now owns 116 shares of the company's stock worth $40,000 after purchasing an additional 50 shares during the period. 62.73% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities research analysts have commented on HCA shares. Morgan Stanley dropped their target price on HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating on the stock in a report on Monday, July 28th. Wells Fargo & Company dropped their target price on HCA Healthcare from $385.00 to $375.00 and set an "equal weight" rating on the stock in a report on Thursday, August 14th. Cantor Fitzgerald reissued an "overweight" rating and issued a $444.00 target price on shares of HCA Healthcare in a report on Tuesday. Robert W. Baird boosted their target price on HCA Healthcare from $380.00 to $423.00 and gave the stock a "neutral" rating in a report on Thursday, August 14th. Finally, Wolfe Research downgraded HCA Healthcare from an "outperform" rating to a "peer perform" rating in a report on Monday, July 28th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $401.83.

HCA Healthcare Price Performance

Shares of NYSE:HCA traded up $2.50 during trading on Thursday, hitting $407.55. 965,359 shares of the company's stock were exchanged, compared to its average volume of 1,154,093. The company has a debt-to-equity ratio of 69.07, a current ratio of 0.98 and a quick ratio of 0.86. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14. The business's 50-day simple moving average is $376.38 and its 200 day simple moving average is $356.08. The company has a market cap of $95.36 billion, a price-to-earnings ratio of 17.13, a PEG ratio of 1.27 and a beta of 1.39.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its earnings results on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The firm had revenue of $18.61 billion during the quarter, compared to analysts' expectations of $18.49 billion. During the same quarter last year, the business posted $5.50 earnings per share. The firm's revenue was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, equities analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th will be given a dividend of $0.72 per share. The ex-dividend date is Tuesday, September 16th. This represents a $2.88 annualized dividend and a dividend yield of 0.7%. HCA Healthcare's dividend payout ratio (DPR) is currently 12.11%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.